{"id":"https://openalex.org/W4384524084","doi":"https://doi.org/10.1093/cei/uxad083","title":"Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes","display_name":"Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes","publication_year":2023,"publication_date":"2023-07-17","ids":{"openalex":"https://openalex.org/W4384524084","doi":"https://doi.org/10.1093/cei/uxad083","pmid":"https://pubmed.ncbi.nlm.nih.gov/37458220","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10714188"},"language":"en","primary_location":{"id":"doi:10.1093/cei/uxad083","doi":"https://doi.org/10.1093/cei/uxad083","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cei/uxad083","pdf_url":"https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad083/50894527/uxad083.pdf","source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad083/50894527/uxad083.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021683292","display_name":"Urs Christen","orcid":"https://orcid.org/0000-0003-4165-7976","observed_orcids":["https://orcid.org/0000-0003-4165-7976"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Urs Christen","raw_affiliation_strings":["Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany"],"raw_orcid":"https://orcid.org/0000-0003-4165-7976","affiliations":[{"raw_affiliation_string":"Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007988649","display_name":"Laetitia Pouzol","orcid":"https://orcid.org/0000-0001-8727-1142","observed_orcids":["https://orcid.org/0000-0001-8727-1142"]},"institutions":[{"id":"https://openalex.org/I4210136915","display_name":"Idorsia (Switzerland)","ror":"https://ror.org/03va9ng43","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915"]},{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Laetitia Pouzol","raw_affiliation_strings":["Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-8727-1142","affiliations":[{"raw_affiliation_string":"Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104009748","display_name":"M\u00e9lanie Tunis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136915","display_name":"Idorsia (Switzerland)","ror":"https://ror.org/03va9ng43","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915"]},{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M\u00e9lanie Tunis","raw_affiliation_strings":["Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057670277","display_name":"Anna Sassi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136915","display_name":"Idorsia (Switzerland)","ror":"https://ror.org/03va9ng43","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915"]},{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Anna Sassi","raw_affiliation_strings":["Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086793789","display_name":"Camilla Tondello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Camilla Tondello","raw_affiliation_strings":["Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Monika Bayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Monika Bayer","raw_affiliation_strings":["Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085217351","display_name":"Edith Hintermann","orcid":"https://orcid.org/0000-0002-0943-8098","observed_orcids":["https://orcid.org/0000-0002-0943-8098"]},"institutions":[{"id":"https://openalex.org/I114090438","display_name":"Goethe University Frankfurt","ror":"https://ror.org/04cvxnb49","country_code":"DE","type":"education","lineage":["https://openalex.org/I114090438"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Edith Hintermann","raw_affiliation_strings":["Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmazentrum Frankfurt, Goethe University Frankfurt , Germany","institution_ids":["https://openalex.org/I114090438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049875519","display_name":"Daniel S. Strasser","orcid":"https://orcid.org/0000-0002-0097-1937","observed_orcids":["https://orcid.org/0000-0002-0097-1937"]},"institutions":[{"id":"https://openalex.org/I4210136915","display_name":"Idorsia (Switzerland)","ror":"https://ror.org/03va9ng43","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915"]},{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Daniel S Strasser","raw_affiliation_strings":["Translational Biomarkers Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Biomarkers Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092485540","display_name":"Sabrina Schuldes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sabrina Schuldes","raw_affiliation_strings":["Project Management Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Project Management Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036056372","display_name":"Ulrich Mentzel","orcid":"https://orcid.org/0000-0001-6026-0072","observed_orcids":["https://orcid.org/0000-0001-6026-0072"]},"institutions":[{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ulrich Mentzel","raw_affiliation_strings":["Pharmacology and Preclinical Development Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology and Preclinical Development Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4405257665"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081955261","display_name":"Marianne M. A. Martinic","orcid":"https://orcid.org/0000-0003-4407-3423","observed_orcids":["https://orcid.org/0000-0003-4407-3423"]},"institutions":[{"id":"https://openalex.org/I4210136915","display_name":"Idorsia (Switzerland)","ror":"https://ror.org/03va9ng43","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915"]},{"id":"https://openalex.org/I4405257665","display_name":"Idorsia Pharmaceuticals Ltd (Switzerland)","ror":"https://ror.org/05j00sy30","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Marianne M Martinic","raw_affiliation_strings":["Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-4407-3423","affiliations":[{"raw_affiliation_string":"Immunology and Pharmacology Department, Idorsia Pharmaceuticals Ltd. , Hegenheimermattweg 91, Allschwil , Switzerland","institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007988649","https://openalex.org/A5081955261"],"corresponding_institution_ids":["https://openalex.org/I4210136915","https://openalex.org/I4405257665"],"apc_list":{"value":2650,"currency":"GBP","value_usd":3296},"apc_paid":{"value":2650,"currency":"GBP","value_usd":3296},"fwci":1.7806,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.85180464,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"214","issue":"2","first_page":"131","last_page":"143"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9810000061988831},{"id":"https://openalex.org/keywords/anti-cd3-antibody","display_name":"anti-CD3 antibody","score":0.8650000095367432},{"id":"https://openalex.org/keywords/cxcr3-antagonist","display_name":"CXCR3 antagonist","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9440000057220459},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.890999972820282},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.9269999861717224},{"id":"https://openalex.org/keywords/insulitis","display_name":"insulitis","score":0.9139999747276306},{"id":"https://openalex.org/keywords/t-cell-lymphopenia","display_name":"T-cell lymphopenia","score":0.5870000123977661},{"id":"https://openalex.org/keywords/islet-autoimmunity","display_name":"islet autoimmunity","score":0.6629999876022339},{"id":"https://openalex.org/keywords/nod-mice","display_name":"NOD mice","score":0.6290000081062317},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.7179999947547913},{"id":"https://openalex.org/keywords/beta-cell-destruction","display_name":"beta cell destruction","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C2779511750","wikidata":"https://www.wikidata.org/wiki/Q922215","display_name":"Insulitis","level":4,"score":0.8596276044845581},{"id":"https://openalex.org/C25532541","wikidata":"https://www.wikidata.org/wiki/Q655541","display_name":"CXCR3","level":5,"score":0.617560625076294},{"id":"https://openalex.org/C2778013207","wikidata":"https://www.wikidata.org/wiki/Q1961243","display_name":"NOD mice","level":4,"score":0.6066923141479492},{"id":"https://openalex.org/C165220095","wikidata":"https://www.wikidata.org/wiki/Q207524","display_name":"Islet","level":3,"score":0.5483081340789795},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5315399169921875},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5310754179954529},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.4949771761894226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48954758048057556},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4849739074707031},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.47705402970314026},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.45211848616600037},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.415585458278656},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.40126362442970276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3526971936225891},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.33523160219192505},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23068949580192566},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.20628300309181213},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.1301458775997162},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016688","descriptor_name":"Mice, Inbred NOD","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054367","descriptor_name":"Receptors, CXCR3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/cei/uxad083","doi":"https://doi.org/10.1093/cei/uxad083","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cei/uxad083","pdf_url":"https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad083/50894527/uxad083.pdf","source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10714188","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10714188","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10714188/pdf/uxad083.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},{"id":"pmid:37458220","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37458220","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental immunology","raw_type":"Journal Article"},{"id":"pmh:oai:publikationen.ub.uni-frankfurt.de:83398","doi":null,"is_oa":true,"landing_page_url":"https://nbn-resolving.org/urn:nbn:de:hebis:30:3-833982","pdf_url":null,"source":{"id":"https://openalex.org/S4306400432","display_name":"Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114090438","host_organization_name":"Goethe University Frankfurt","host_organization_lineage":["https://openalex.org/I114090438"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1093/cei/uxad083","doi":"https://doi.org/10.1093/cei/uxad083","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cei/uxad083","pdf_url":"https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad083/50894527/uxad083.pdf","source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320329429","display_name":"Idorsia Pharmaceuticals","ror":"https://ror.org/03va9ng43"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4384524084.pdf","grobid_xml":"https://content.openalex.org/works/W4384524084.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1484857603","https://openalex.org/W1517524419","https://openalex.org/W1779557997","https://openalex.org/W1823467089","https://openalex.org/W1896586019","https://openalex.org/W1995201985","https://openalex.org/W1997773579","https://openalex.org/W2009253992","https://openalex.org/W2032218738","https://openalex.org/W2046749316","https://openalex.org/W2057043713","https://openalex.org/W2057328452","https://openalex.org/W2066572646","https://openalex.org/W2074463323","https://openalex.org/W2082137006","https://openalex.org/W2090613865","https://openalex.org/W2094736478","https://openalex.org/W2097687485","https://openalex.org/W2098954537","https://openalex.org/W2103302952","https://openalex.org/W2146664729","https://openalex.org/W2162789526","https://openalex.org/W2164707000","https://openalex.org/W2169510681","https://openalex.org/W2169866299","https://openalex.org/W2544255112","https://openalex.org/W2554850815","https://openalex.org/W2746133516","https://openalex.org/W2805560670","https://openalex.org/W2807893746","https://openalex.org/W2887373570","https://openalex.org/W2904763939","https://openalex.org/W2948104235","https://openalex.org/W3093241120","https://openalex.org/W3111471920","https://openalex.org/W3120451096","https://openalex.org/W3133678581","https://openalex.org/W3216791550","https://openalex.org/W4313621194","https://openalex.org/W4323294961","https://openalex.org/W4323533159","https://openalex.org/W4385302724","https://openalex.org/W6784731513"],"related_works":["https://openalex.org/W1779557997","https://openalex.org/W7055388689","https://openalex.org/W2026549470","https://openalex.org/W4281704273","https://openalex.org/W2172266085","https://openalex.org/W3039182895","https://openalex.org/W1607870572","https://openalex.org/W1997532168","https://openalex.org/W1982671158","https://openalex.org/W3010055021"],"abstract_inverted_index":{"Treatment":[0],"of":[1,17,31,55,67,73,100,243,250],"patients":[2,251],"with":[3,8,83,245,252],"recent-onset":[4,253],"type":[5],"1":[6],"diabetes":[7,129,219],"an":[9],"anti-CD3":[10,40,84,101,246],"antibody":[11],"leads":[12],"to":[13,190,225,239],"the":[14,29,39,53,60,65,71,123,152,156,194,221,241,248],"transient":[15,162],"stabilization":[16],"C-peptide":[18,148,207],"levels":[19],"in":[20,52,110,122,172,184,198,213,229],"responder":[21],"patients.":[22],"Partial":[23],"efficacy":[24],"may":[25,86],"be":[26],"explained":[27],"by":[28,35,64,114],"entry":[30],"islet-reactive":[32],"T-cells":[33],"spared":[34,165],"and/or":[36],"regenerated":[37],"after":[38],"therapy.":[41],"The":[42,98,137],"CXCR3/CXCL10":[43],"axis":[44,75],"has":[45],"been":[46],"proposed":[47],"as":[48],"a":[49,78],"key":[50],"player":[51],"infiltration":[54,89],"autoreactive":[56],"T":[57,168],"cells":[58],"into":[59],"pancreatic":[61],"islets":[62],"followed":[63],"destruction":[66],"\u03b2":[68],"cells.":[69,169],"Combining":[70],"blockade":[72],"this":[74],"using":[76],"ACT-777991,":[77],"novel":[79],"small-molecule":[80],"CXCR3":[81,108],"antagonist,":[82],"treatment":[85,102,119,154,160,223,249],"prevent":[87],"further":[88],"and":[90,93,127,146,155,177,204,237],"\u03b2-cell":[91],"damage":[92],"thus,":[94],"preserve":[95],"insulin":[96],"production.":[97],"effect":[99],"on":[103,139],"circulating":[104,166],"T-cell":[105],"subsets,":[106],"including":[107],"expression,":[109],"mice":[111,197,217],"was":[112,120],"evaluated":[113,150],"flow":[115],"cytometry.":[116],"Anti-CD3/ACT-777991":[117],"combination":[118,153,222,242],"assessed":[121],"virally":[124],"induced":[125,161],"RIP-LCMV-GP":[126],"NOD":[128,216],"mouse":[130,174],"models.":[131],"Treatments":[132],"started":[133],"at":[134,218],"disease":[135,186,199,227],"onset.":[136],"effects":[138],"remission":[140,187,200,228],"rate,":[141],"blood":[142,180],"glucose":[143,181],"concentrations,":[144,182],"insulitis,":[145],"plasma":[147,206],"were":[149,211],"for":[151,247],"respective":[157],"monotherapies.":[158],"Anti-CD3":[159],"lymphopenia":[163],"but":[164],"CXCR3+":[167],"Combination":[170],"therapy":[171],"both":[173],"models":[175],"synergistically":[176],"persistently":[178],"reduced":[179,202],"resulting":[183],"increased":[185],"rates":[188],"compared":[189],"each":[191],"monotherapy.":[192],"At":[193],"study":[195],"end,":[196],"demonstrated":[201],"insulitis":[203],"detectable":[205],"levels.":[208],"When":[209],"treatments":[210],"initiated":[212],"non-severely":[214],"hyperglycemic":[215],"onset,":[220],"led":[224],"persistent":[226],"all":[230],"mice.":[231],"These":[232],"results":[233],"provide":[234],"preclinical":[235],"validation":[236],"rationale":[238],"investigate":[240],"ACT-777991":[244],"diabetes.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-18T00:00:00"}